RT Journal Article
SR Electronic
T1 Anaesthesia and infection control in cesarean section of pregnant women with coronavirus disease 2019 (COVID-19)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.23.20040394
DO 10.1101/2020.03.23.20040394
A1 Yue, LinLi
A1 Han, Lefei
A1 Li, Qiannan
A1 Zhong, Min
A1 Wang, Jun
A1 Wan, Zhenzhen
A1 Chu, Caijuan
A1 Zeng, Yi
A1 Peng, Min
A1 Yang, Lin
A1 Li, Na
YR 2020
UL http://medrxiv.org/content/early/2020/03/27/2020.03.23.20040394.abstract
AB Background The coronavirus disease 2019 (COVID-19) first emerged in Wuhan, China, and soon caused an ongoing pandemic globally. In this study we conducted a retrospective study to evaluate the safety and efficacy of combined spinal-epidural anaesthesia (CSEA) and infection control measures on perinatal care quality of 30 pregnant women with confirmed and suspected COVID-19.Methods Individual demographic data, clinical outcomes, laboratory investigations of pregnant women and their newborns were collected from electronic medical records of the Maternal and Children Health Hospital of Hubei Province, during January 24 to February 29, 2020. Anaesthesia and surgery results were compared between pregnant women with confirmed and suspected COVID-19 infection.Results Using CSEA in cesarean section was effective and safe for pregnant women with confirmed and suspected COVID-19 infection. Administration of dezocine and morphine was effective as postoperative analgesia, and well tolerated in COVID-19 patients. The assessment of surgery outcomes also showed similar results in both confirmed and suspected cases. No respiratory failure nor distress were found in the mothers with confirmed COVID-19 infection and their neonates. None of these patients experienced severe obstetric complications related to anaesthesia and surgeries. No COVID-19 infection was reported in the neonates born to the mothers with confirmed COVID-19 infection and healthcare workers in these operations.Conclusions In cesarean section for pregnant women with COVID-19 infection, CSEA was safe and efficient in achieving satisfactory obstetrical anaesthesia and postoperative analgesia. No cross-infection occurred in the HCWs working in these operations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNL is supported by the Joint Fund of the Hubei Provincial Health Commission. LY is supported by the General Research Fund of the Hong Kong Polytechnic University.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and materials used in this work were available based on request.